Archives of Microbiology

, Volume 192, Issue 6, pp 477–484 | Cite as

Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model

  • Simone V. Generoso
  • Mirelle Viana
  • Rosana Santos
  • Flaviano S. Martins
  • José A. N. Machado
  • Rosa M. E. Arantes
  • Jacques R. Nicoli
  • Maria I. T. D. Correia
  • Valbert N. Cardoso
Original Paper


Probiotic is a preparation containing microorganisms that confers beneficial effect to the host. This work assessed whether oral treatment with viable or heat-killed yeast Saccharomyces cerevisiae strain UFMG 905 prevents bacterial translocation (BT), intestinal barrier integrity, and stimulates the immunity, in a murine intestinal obstruction (IO) model. Four groups of mice were used: mice undergoing only laparotomy (CTL), undergoing intestinal obstruction (IO) and undergoing intestinal obstruction after previous treatment with viable or heat-killed yeast. BT, determined as uptake of 99mTc-E. coli in blood, mesenteric lymph nodes, liver, spleen and lungs, was significantly higher in IO group than in CTL group. Treatments with both yeasts reduced BT in blood and all organs investigated. The treatment with both yeasts also reduced intestinal permeability as determined by blood uptake of 99mTc-DTPA. Immunological data demonstrated that both treatments were able to significantly increase IL-10 levels, but only viable yeast had the same effect on sIgA levels. Intestinal lesions were more severe in IO group when compared to CTL and yeasts groups. Concluding, both viable and heat-killed cells of yeast prevent BT, probably by immunomodulation and by maintaining gut barrier integrity. Only the stimulation of IgA production seems to depend on the yeast viability.


Probiotic Bacterial translocation Intestinal permeability Intestinal obstruction sIgA IL-10 



The study was supported by grants from Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Pesquisa (CNPq). The authors thank Dr. Carlos A. Rosa for providing the yeast S. cerevisiae 905.


  1. Akin ML, Uluutku H, Erenglu C, Ilicak EN, Elbuken E, Erdemoglu A, Celenk T (2002) Hyperbaric oxygen ameliorates bacterial translocation in rats with mechanical intestinal obstruction. Dis Colon Rectum 45:967–972CrossRefPubMedGoogle Scholar
  2. Aldemir M, Kökoglu OF, Geyik MF, Büyükbayram H (2002) Effects of octreotideacetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 198:1–9CrossRefPubMedGoogle Scholar
  3. Buts JP, de Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51:1485–1492CrossRefPubMedGoogle Scholar
  4. Chang TMC, Lu RH, Tsai LM (2001) Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 95:133–140CrossRefPubMedGoogle Scholar
  5. Ciriello CJ, Lachance MA (2001) YEASTCOMPARE. University of Western Ontario, LondonGoogle Scholar
  6. Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4:733–739CrossRefPubMedGoogle Scholar
  7. Dalmasso D, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-α induced apoptosis in EHEC-infected T84 cells. Res Microbiol 55:1–10Google Scholar
  8. Deitch EA (2002) Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 131:241–244CrossRefPubMedGoogle Scholar
  9. Diniz ASOF, Resende BM, Nunan EA, Simal CJR, Cardoso VN (1999) 99mTechnetium labelled Escherichia coli. Appl Rad Isot 51:33–36CrossRefGoogle Scholar
  10. FAO/WHO Report (2002) Food and Agricultural Organization/World Health Organization Working Group. Guidelines for the evaluation of probiotics in food, London, Ontario, Canada, April 30 and May 1Google Scholar
  11. Fietto JLR, Araújo RS, Valadão FN, Fietto LG, Brandão RL, Neves MJ, Gomes CO, Nicoli JR, Castro IM (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50:615–621CrossRefPubMedGoogle Scholar
  12. Gatt M, Reddy BS, Macfie J (2007) Review article: bacterial translocation in the critically ill evidence and methods of prevention. Aliment Pharmacol 25:741–757CrossRefGoogle Scholar
  13. Gedek BR (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42:261–264CrossRefPubMedGoogle Scholar
  14. Geyik MF, Aldemir M, Hosoglu S, Ayaz C, Satilmis S, Buyukbayram H, Kokoglu OF (2006) The effects of Saccharomyces boulardii on bacterial translocation in rats with obstruction jaundice. Ann Rev Coll Surg Engl 88:178–180Google Scholar
  15. Grimbaldeston M, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8:1095–1104CrossRefPubMedGoogle Scholar
  16. Hajishengallis G, Nikolova E, Russel MW (1992) Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A antibodies to the cell surface protein antigen I/II: reversal by IgA 1 protease cleavage. Infect Immun 60:5057–5064PubMedGoogle Scholar
  17. Herek O, Kara IG, Kaleli I (2004) Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury. Surg Today 34:256–260CrossRefPubMedGoogle Scholar
  18. Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Hara ST, Umesaki Y (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 16:2511–2516CrossRefGoogle Scholar
  19. Jorgensen B, Keller A, Radvanska E, Rittig S, Taagehoj-Jensen F, Frokiaer J, Jorgensen T, Pedersen M (2006) Reproducibility of contrast enhanced magnetic resonance renography in adolescents. J Urol 176:1171–1176CrossRefPubMedGoogle Scholar
  20. Kataria J, Li N, Wynn JL, Neu J (2009) Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67:546–550CrossRefPubMedGoogle Scholar
  21. Kumura H, Tanoue Y, Tsukahara M, Tanaka T, Shimazaki K (2004) Screening of dairy yeast strains for probiotic applications. J Dairy Sci 87:4050–4056CrossRefPubMedGoogle Scholar
  22. Li N, Russell WM, Douglas-Escobar M, Hauser N, Lopez M, Neu J (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on pro-inflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 66:203–207CrossRefPubMedGoogle Scholar
  23. Lichtman SM (2001) Bacterial translocation in humans. J Pediatr Gastroenterol Nutr 33:1–10CrossRefPubMedGoogle Scholar
  24. Martins FS, Nardi RMD, Arantes RME, Rosa CA, Neves MJ, Nicoli JR (2005) Screening of yeast as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 51:83–92CrossRefPubMedGoogle Scholar
  25. Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, Arantes RME, Nardi RMD, Neves MJ, Nicoli JR (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56:352–359CrossRefPubMedGoogle Scholar
  26. Martins FS, Silva AA, Vieira AT, Barbosa FHF, Arantes RME, Teixeira MM, Nicoli JR (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191:623–630CrossRefPubMedGoogle Scholar
  27. Miyauchi E, Morita H, Tanabe S (2009) Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J Dairy Sci 92:2400–2408CrossRefPubMedGoogle Scholar
  28. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, WashingtonGoogle Scholar
  29. Oliveira MA, Lemos DL, Diniz ASOF, Coelho J, Cardoso VN (2006) Prevention of bacterial translocation using glutamine: a new strategy of investigation. Nutrition 22:419–424CrossRefPubMedGoogle Scholar
  30. Quirino IEP, Correia MITD, Cardoso VN (2007) The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr 26:335–340CrossRefPubMedGoogle Scholar
  31. Sun Z, Wang X, Deng X, Lasson A, Wallén R, Hallberg E, Andersson R (1998) The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats. Shock 10:203–212CrossRefPubMedGoogle Scholar
  32. Surawicz CM (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 17:775–783CrossRefPubMedGoogle Scholar
  33. Tannock G (2005) Probiotics and prebiotics: scientific aspects, 1st edn. Caister Academic Press, University of Otago, DunedinGoogle Scholar
  34. Tiago FCP, Martins FS, Rosa CA, Nardi RMD, Cara DC, Nicoli JR (2009) Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function. World J Microbiol Biotechnol 25:657–666CrossRefGoogle Scholar
  35. Viana M, Santos R, Generoso S, Arantes R, Correia M, Cardoso V (2009) Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition 26:218–233CrossRefPubMedGoogle Scholar
  36. Wiest R, Rath HC (2003) Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17:397–425CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Simone V. Generoso
    • 1
  • Mirelle Viana
    • 1
  • Rosana Santos
    • 1
  • Flaviano S. Martins
    • 2
    • 3
  • José A. N. Machado
    • 5
  • Rosa M. E. Arantes
    • 4
  • Jacques R. Nicoli
    • 3
  • Maria I. T. D. Correia
    • 6
  • Valbert N. Cardoso
    • 1
  1. 1.Departamento De Análises Clínicas e Toxicológicas, Faculdade de FarmáciaUniversidade Federal de Minas GeraisBelo HorizonteBrazil
  2. 2.Departamento de Bioquímica e Imunologia, Instituto de Ciências BiológicasUniversidade Federal de Minas GeraisBelo HorizonteBrazil
  3. 3.Departamento de Microbiologia, Instituto de Ciências BiológicasUniversidade Federal de Minas GeraisBelo HorizonteBrazil
  4. 4.Departamento de Patologia Geral, Instituto de Ciências BiológicasUniversidade Federal de Minas GeraisBelo HorizonteBrazil
  5. 5.Hospital Santa CasaNúcleo de Pesquisa em Pós-GraduaçãoBelo HorizonteBrazil
  6. 6.Departamento de Cirurgia, Faculdade de MedicinaUniversidade Federal de Minas GeraisBelo HorizonteBrazil

Personalised recommendations